Erik Schropp

Erik Schropp, a member of the Board of Directors of PolyPeptide Group, is a Dutch citizen born in 1964. Mr. Schropp has served as a member of the Board of Directors of PolyPeptide Laboratories Holding B.V. since 2017. Currently, he is CEO of C&P Investors Limited and a director of Draupnir Holding B.V., The Netherlands. Previously, Mr. Schropp held various finance functions in the pharmaceutical industry. Further, Mr. Schropp serves as a member of the Board of Directors of various privately held companies engaged in the fields of life sciences, gene therapy, and venture capital investment. Mr. Schropp holds a Master’s degree in Economics & Tax from the Erasmus University Rotterdam, The Netherlands.